Related Experiment Video
Updated: May 7, 2026

Isolation of Macrophage Subsets and Stromal Cells from Human and Mouse Myocardial Specimens
Published on: December 17, 2019
Recruited macrophages elicit atrial fibrillation
Maarten Hulsmans1,2, Maximilian J Schloss1,2, I-Hsiu Lee1,2
1Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Insights
Immune cells, specifically SPP1+ macrophages, drive atrial fibrillation by disrupting heart contractions. Targeting these macrophages offers a new therapeutic strategy for preventing stroke and heart failure.
Area of Science:
- Cardiovascular Research
- Immunology
- Cell Biology
Background:
- Atrial fibrillation (AF) impairs atrial contraction, increasing risks of stroke and heart failure.
- The roles of immune and stromal cells in AF pathogenesis remain incompletely understood.
Purpose of the Study:
- To investigate the contribution of immune and stromal cells to atrial fibrillation.
- To identify specific cellular players and molecular mechanisms driving AF.
Main Methods:
- Single-cell RNA sequencing of human and mouse atria.
- Development of a mouse model combining hypertension, obesity, and mitral valve regurgitation (HOMER).
- Genetic manipulation (Ccr2 knockout, Spp1 deletion) and cell-cell interaction analysis.
Main Results:
- Single-cell transcriptomics revealed expansion of inflammatory monocytes and SPP1+ macrophages in human and HOMER mouse atria.
- HOMER mice exhibited enlarged, fibrotic, and AF-prone atria, mirroring human pathology.
- Inhibiting monocyte migration (Ccr2-/-) and deleting Spp1 reduced AF incidence in HOMER mice.
- SPP1 was identified as a key signaling molecule mediating cross-talk between immune and stromal cells, promoting AF.
Conclusions:
- SPP1+ macrophages are key drivers of atrial fibrillation.
- Targeting SPP1+ macrophages represents a potential immunotherapeutic strategy for AF.
- Understanding immune-stromal cell interactions is crucial for developing novel AF treatments.
Abstract:
Atrial fibrillation disrupts contraction of the atria, leading to stroke and heart failure. We deciphered how immune and stromal cells contribute to atrial fibrillation. Single-cell transcriptomes from human atria documented inflammatory monocyte and SPP1+ macrophage expansion in atrial fibrillation. Combining hypertension, obesity, and mitral valve regurgitation (HOMER) in mice elicited enlarged, fibrosed, and fibrillation-prone atria. Single-cell transcriptomes from HOMER mouse atria recapitulated cell composition and transcriptome changes observed in patients. Inhibiting monocyte migration reduced arrhythmia in Ccr2-∕- HOMER mice. Cell-cell interaction analysis identified SPP1 as a pleiotropic signal that promotes atrial fibrillation through cross-talk with local immune and stromal cells. Deleting Spp1 reduced atrial fibrillation in HOMER mice. These results identify SPP1+ macrophages as targets for immunotherapy in atrial fibrillation.
Related Concept Videos
Structure of Cardiac Muscles
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Specialized Characteristics of Cardiac Muscles
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy...

